Physical activity as measured by accelerometry in children receiving growth hormone.
OBJECTIVE
Parents of children treated with growth hormone (GH) frequently report to the paediatrician that their children have become more physically active. In the present study, activity patterns of GH-treated children were measured and compared to those of healthy controls.


METHODS
Subjects were 25 children at the start of GH treatment (age 8.4 +/- 2.6 y) and 19 age- and gender-matched controls (age 8.8 +/- 3.2 y). Physical activity was assessed with a tri-axial accelerometer for movement registration over two separate 2-wk intervals, one before the start of GH treatment and one 2 wk after the start of treatment. GH-treated subjects were categorized as poor responders (change in height over 1 y <0.7 SDS, n = 15) or good responders (change in height over 1 y >0.7 SDS, n = 10).


RESULTS
Before therapy, good responders showed a significantly lower physical activity compared to healthy controls, spending significantly less time on high-intensity activities. This difference disappeared 2 wk after the start of therapy. Physical activity in poor responders was not significantly different from controls before and after 2 wk of GH therapy.


CONCLUSIONS
Children who respond well to GH therapy (change in height >0.7 SDS) showed a reduced amount of physical activity before therapy, which was normalized after 2 wk of GH therapy.
Hoos
M B
MB
Department of Paediatrics, University of Maastricht, Maastricht, The Netherlands. marije.hoos@kg.unimaas.nl
Westerterp
K R
KR
Kuipers
H
H
Schuwirth
L
L
Gerver
W J M
WJ
D001120:Arginine; D002648:Child; D003000:Clonidine; D004393:Dwarfism, Pituitary / Q000188:drug therapy; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D012890:Sleep / Q000502:physiology
D013006:Growth Hormone; D001120:Arginine; D003000:Clonidine